Effect of miR-34b overexpression on the radiosensitivity of non-small cell lung cancer cell lines

Anticancer Research

Volumn 32, Issue 5, 2012, Pages 1603-1610

  Balça Silva, Joana ^a   Neves, Sílvia Sousa ^a   Gonçalves, Ana Cristina ^a   Abrantes, Ana Margarida ^b   Casalta Lopes, João ^b   Botelho, Maria Filomena ^b   Sarmento Ribeiro, Ana Bela ^a   Silva, Henriqueta Coimbra ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

A549; Apoptosis; BCL2; H1299 cell line; MicroRNAs; miR 34 familly; Non small cell lung cancer; p53; Radioresistance

Indexed keywords

MICRORNA; MICRORNA 34A; MICRORNA 34B; MICRORNA 34C; PROTEIN BCL 2; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER RADIOTHERAPY; CELL SURVIVAL; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE; RADIOSENSITIVITY; WILD TYPE;

CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICRORNAS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RADIATION TOLERANCE; RAS PROTEINS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84861496878     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Riley PA: Free radicals in biology: Oxidative stress and the effects of ionizing radiation. Int J Radiat Biol 65: 27-33, 1994.
2. Falck J, Mailand N, Syljuåsen RG, Bartek J and Lukas J: The ATM-CHK2-CDC25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 410: 842-847, 2001.
3. Harper JW and Elledge SJ: The DNA damage response: ten years after. Mol Cell 28: 739-745, 2007.
4. Brambilla E and Gazdar A: Pathogenesis of lung cancer signalling pathways: roadmap for therapies. Eur Respir J 33: 1485-1497, 2009.
5. Sato M, Shames DS, Gazdar AF and Minna JD: A translational view of the molecular pathogenesis of lung cancer. J Thorac Oncol 2: 327-343, 2007. (Pubitemid 47181718)
6. Fei P and El-Deiry WS: p53 and radiation responses. Oncogene 22: 5774-5783, 2003. (Pubitemid 37176699)
7. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW: Participation of p53 protein in the cellular response to DNA damage. Cancer Res pp. 6304-6311, 1991.
8. Vogelstein B, Lane D and Levine AJ: Surfing the p53 network. Nature 408: 307-310, 2000.
9. Vousden KH: Activation of the p53 tumor suppressor protein. Biochim Biophys Acta 1602: 47-59, 2002.
10. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
11. Zhang B, Pan X, Cobb GP and Anderson TA: MicroRNAs as oncogenes and tumor suppressors. Dev Biol 302: 1-312, 2007.
12. Bommer GT, Gerin I, Feng Y, Kaczorowski AJ, Kuick R, Love RE, Zhai Y, Giordano TJ, Qin ZS, Moore BB, MacDougald OA, Cho KR and Fearon ER: p53-Mediated activation of miRNA34 candidate tumor-supressor genes. Curr Biology 17: 1298-1307, 2007. (Pubitemid 47176893)
13. Kumar MS, Erkeland SJ, Pester RE, Chen CY, Ebert MS, Sharp PA and Jacks T: Suppression of non-small cell lung tumour development by the let-7 microRNA family. Proc Natl Acad Sci USA 105: 3903-3908, 2008. (Pubitemid 351723497)
14. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM and Harris CC: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198, 2006. (Pubitemid 43357945)
15. Yang Y, Li X, Yang Q, Wang X, Zhou Y, Jiang T, Ma Q and Wang YJ: The role of microRNA in human lung squamous cell carcinoma. Cancer Genet Cytogenet 200: 127-133, 2010.
16. Raponi M, Dossey L, Jatkoe T, Wu X, Chen G, Fan H and Beer DG: MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. Cancer Res 69: 5776-5783, 2009.
17. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, Jackson AL, Linsley PS, Chen C, Lowe SW, Cleary MA and Hannon GJ: A microRNA component of the p53 tumour suppressor network. Nature 447: 1130-1134, 2007. (Pubitemid 47014436)
18. Corney DC, Flesken-Nikitin A, Godwin AK, Wang W and Nikitin AY: MicroRNA-34b and microRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesionindependent growth. Cancer Res 67: 8433-8438, 2007. (Pubitemid 47437414)
19. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M, Ferlito M, Lowenstein CJ, Arking DE, Beer MA, Maitra A and Mendell JT: Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26(5): 731-743, 2007.
20. Ji Q, Hao X, Meng Y, Zhang M, Desano J, Fan D and Xu L: Restoration of tumor suppressor miR-34 inhibits human p53- mutant gastric cancer tumorspheres. BMC Cancer 8: 1-12, 2008.
21. Kumamoto K, Spillare EA, Fujita K, Horikawa I, Yamashita T, Appella E, Nagashima M, Takenoshita S, Yokota J and Harris CC: Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b and mir-34c expression and induced senescence. Cancer Res 68: 3193-3203, 2008.
22. Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N, Bentwich Z and Oren M: Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 26: 731-743, 2007. (Pubitemid 46856247)
23. Blower PE, Chung J-H, Verducci JS, Lin S, Park JK, Dai Z, Liu CG, Schmittgen TD, Reinhold WC, Croce CM, Weinstein JN and Sadee W: MicroRNAs modulate the chemosensitivity of tumor cells. Mol Cancer Ther 7: 1-9, 2008.
24. Palayoor ST, Arrayankalayil MJ, Shoaibi A and Coleman CN: Radiation sensitivity of human carcinoma cells transfected with small interfering RNA against cyclooxygenase-2. Clin Cancer Res 11: 6980-6986, 2005. (Pubitemid 41428757)
25. Weidhaas JB, Babar I, Nallur SM, Trang P, Roush S, Boehm M, Gillespie E and Slack FJ: MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy. Cancer Res 67: 11111-11116, 2007. (Pubitemid 350248533)
26. Fujita Y, Kojima K, Hamada N, Ohhashi R, Akao Y, Nozawa Y, Deguchi T and Ito M: Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells. Biochem Biophys Res Commun 377: 114-119, 2008.
27. Hayashi S, Hatashita M, Matsumoto H, Shioura H, Kitai R and Kano E: Enhancement of radiosensitivity by topoisomerase II inhibitor, amrubicin and amrubicinol, in human lung adenocarcinoma A549 cells and kinetics of apoptosis and necrosis induction. Int J Mol Med 18: 909-915, 2006.
28. Tanaka N, Toyooka S, Soh J, Kubo T, Yamamoto H, Maki Y, Muraoka T, Shien K, Furukawa M, Ueno T, Asano H, Tsukuda K, Aoe K and Miyoshi S: Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer. Lung Cancer 76(1): 32-38, 2012.
29. Ji Q, Hao X, Meng Y, Zhang M, Desano J, Fan D and Xu L: Restoration of tumor suppressor miR-34 inhibits human p53- mutant gastric cancer tumorspheres. BMC Cancer 8: 266, 2008.
30. Guo WF, Lin RX, Huang J, Zhou Z, Yang J, Guo GZ and Wang SQ: Identification of differentially expressed genes contributing to radioresistance in lung cancer cells using microarray analysis. Radiat Res 164: 27-35, 2005. (Pubitemid 40885227)
31. Tarasov V, Jung P, Verdoodt B, Lodygin D, Epanchintsev A, Menssen A, Meister G and Hermeking H: Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1 arrest. Cell Cycle 6: 1586-1593, 2007. (Pubitemid 47327945)
32. Chen N and Karantza-Wadsworth V: Role and regulation of autophagy in cancer. Biochim Biophys Acta 1793: 1516-1523, 2009.
33. Zois CE and Koukourakis MI: Radiation-induced autophagy in normal and cancer cells: Towards novel cytoprotection and radio-sensitization policies? Autophagy 5: 442-450, 2009.
34. Zhu CQ, da Cunha Santos G, Ding K, Sakurada A, Cutz JC, Liu N, Zhang T, Marrano P, Whitehead M, Squire JA, Kamel-Reid S, Seymour L, Shepherd FA and Tsao MS: Role of KRAS and EGFR as biomarkers of response to erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21. J Clin Oncol 26: 4268-4275, 2008.